An article on TransTech Pharma Inc. in the Aug. 7, 2001, issue of BioWorld Today incorrectly identified the company¿s RAGE technology. That is an acronym for ¿Receptor for Advanced Glycation Endproducts.¿ Athersys Inc. is the owner of ¿Random Activation of Gene Expression,¿ its RAGE technology.

Editor¿s Note: The correction has been made in BioWorld Online.